Summit Therapeutics Inc. (SMMT) stock analysis
SMMT · Summit Therapeutics Inc.
Latest recorded price: USD 11.82
Sector and industry: Healthcare · Biotechnology
Fiscal 2024 figures: revenue growth -100.0%. The model flags 1 risk signal for this company (1 high severity).